4
MARKET OVERVIEW
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Summarizes the competitive environment, macro signals, and segment-level movements driving market outcomes.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN THE ORTHOPEDIC BIOMATERIALS MARKET
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022-2024)
5.5.2
AVERAGE SELLING PRICE TREND, BY COUNTRY (2024)
5.6.1
IMPORT SCENARIO (HS CODE 7221)
5.6.2
EXPORT SCENARIO (HS CODE 7221)
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF – ORTHOPEDIC BIOMATERIALS MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.11.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
PRECISION TECHNOLOGY
6.2
ADJACENT TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON ORTHOPEDIC BIOMATERIALS MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
CASE STUDIES OF AI IMPLEMENTATION IN THE ORTHOPEDIC BIOMATERIALS MARKET
6.6.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE ORTHOPEDIC BIOMATERIALS MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
ORTHOPEDIC BIOMATERIALS MARKET, BY TYPE, 2023-2030 (USD MILLION)
COMPARATIVE ASSESSMENT OF KEY PRODUCTS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
9.2
METALLIC BIOMATERIALS
9.2.2
TITANIUM & TITANIUM ALLOYS
9.2.3
COBALT-CHROME ALLOYS
9.2.7
OTHER METALLIC BIOMATERIALS
9.3
POLYMERIC BIOMATERIALS
9.3.1
POLYMETHYLMETHACRYLATE (PMMA)
9.3.5
POLYETHERETHERKETONE (PEEK)
9.3.6
OTHER POLYMERIC BIOMATERIALS
9.5.9
OTHER NATURAL BIOMATERIALS
11
ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
APPLICATION-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS PHARMACEUTICAL FILTRATION ADOPTION IN DIVERSE INDUSTRIES
11.2.3
SHOULDER REPLACEMENTS
11.2.4
OTHER JOINT REPLACEMENT APPLICATIONS
11.3.2
MINIMALLY INVASIVE FUSION
11.3.3
MOTION PRESERVATION & DYNAMIC STABILIZATION
11.3.3.1
PEDICLE-BASED ROD SYSTEMS
11.3.3.2
INTERSPINOUS SPACERS
11.3.3.3
ARTIFICIAL DISCS
11.4
BIORESORBABLE TISSUE FIXATION
11.4.2
INTERFERENCE SCREWS
11.4.3
MENISCAL REPAIR TACKS
12
ORTHOPEDIC BIOMATERIALS MARKET, BY REGION, 2023-2030 (USD MILLION)
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
8.2.3
MACROECONOMIC OUTTLOOK FOR NORTH AMERICA
8.3.7
MACROECONOMIC OUTTLOOK FOR EUROPE
8.4.6
REST OF ASIA PACIFIC
8.4.7
MACROECONOMIC OUTTLOOK FOR APAC
8.5.4
REST OF LATIN AMERICA
8.5.5
MACROECONOMIC OUTTLOOK FOR LATIN AMERICA
8.6.1.1
SAUDI ARABIA (KSA)
8.6.1.2
UNITED ARAB EMIRATES (UAE)
8.6.2
REST OF MIDDLE EAST
8.6.3
MACROECONOMIC OUTTLOOK FOR MIDDLE EAST
8.7.1
MACROECONOMIC OUTTLOOK FOR AFRICA
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
13.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
13.3
REVENUE ANALYSIS, 2022-2024
13.4
MARKET SHARE ANALYSIS,
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGION FOOTPRINT
13.5.5.3
PRODUCT FOOTPRINT
13.5.5.4
STERILITY TYPE FOOTPRINT
13.5.5.5
APPLICATION FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
13.7
COMPETITIVE SCENARIO
13.7.3
OTHER DEVELOPMENTS
13.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
13.9
VALUATION AND FINANCIAL METRICS
14.1.1
CELANESE CORPORATION
14.1.2
CARPENTER TECHNOLOGY CORPORATION
14.1.3
EVONIK INDUSTRIES AG
14.1.7
BERKELEYADVANCED MATERIALS
14.1.8
CAM BIOCERAMICS B.V.
15.1.1.1
KEY SOURCES OF SECONDARY DATA
15.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
15.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
15.2
MARKET SIZE ESTIMATION
15.2.1
ORTHOPEDIC BIOMATERIALS MARKET SIZE ESTIMATION
15.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
15.2.1.2
MNM REPOSITORY ANALYSIS
15.2.1.3
SECONDARY ANALYSIS
15.2.1.4
PRIMARY RESEARCH
15.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
15.3
MARKET GROWTH RATE PROJECTIONS
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
AVAILABLE CUSTOMIZATIONS
Growth opportunities and latent adjacency in North America Proteomics Market